Aurora Cannabis(FRA) 21P

Aurora Cannabis Inc. specializes in the cultivation, processing, and sale of cannabis and cannabis-derived products, serving both Canadian and international markets. The company operates through two main divisions: Canadian Cannabis and Plant Propagation, offering a diverse range of products from pharmaceutical-grade cannabis to recreational items.

Products and Services

• Fresh and dried cannabis, oils, and concentrates
• Ingestible forms, capsules, and vaporizable products
• Topical solutions and patient counseling services

Growth Outlook

• Expansion into international markets is underway, enhancing revenue potential
• Increased product offerings aim to capture a larger market share
• Focus on innovation in cannabis-derived products to meet consumer demand

Financial Highlights

• Recent quarterly revenue of 67.64 million CAD shows growth potential
• Trailing twelve months (TTM) gross profit margin stands at 32.08%
• Current ratio of 5.36 indicates strong liquidity position

Aurora Cannabis Inc. has established itself as a key player in the cannabis industry, with a comprehensive product line that caters to various consumer needs. The company's focus on both medical and recreational cannabis positions it well for future growth, particularly as it expands into international markets. Recent financial data indicates a positive trajectory, with a notable increase in quarterly revenue and a solid gross profit margin. The strong current ratio reflects a robust liquidity position, allowing for potential investments in innovation and market expansion. Overall, Aurora Cannabis Inc. presents an intriguing opportunity for investors interested in the evolving cannabis sector.